HelixlyAI Genome Report Prepared for Sample Subject
Report ID HX-2026-0042 · synthetic
Nutrition · Document 12 of 24

Vitamin D

Variants affecting Sample Subject's vitamin D binding and predicted baseline levels, read from GC, VDR, and CYP2R1 genotype. All values below are synthetic and for demonstration only.

3 findings 1 Tier 1 2 Tier 3 Reviewed 2026-01-15

Provenance

Data Provenance verified chain
Document
Vitamin D
Source assembly
GRCh37 (hg19)
Source file SHA-256
0000a1b2c3d4e5f6…4b5c6d7e
Supersedes
prior v1 · SHA 1111f0e9…
Evidence sources
GWAS Catalog, PubMed, dbSNP
Access date
2026-01-15

Per-Gene Findings

Filter:

GC — Vitamin D Binding Protein

Group-specific component · vitamin D transport
GWASTier 1
rs2282679 4:72,608,383 AC

The AC genotype carries one GC low-level allele. This variant associates with lower vitamin D binding protein and lower circulating 25(OH)D.

VDR — FokI Site

Vitamin D receptor · receptor signaling
dbSNPTier 3
rs2228570 12:48,272,895 AG

The AG genotype carries one allele at the VDR FokI site. VDR encodes the vitamin D receptor that mediates downstream vitamin D signaling.

CYP2R1 — 25-Hydroxylase Variant

Cytochrome P450 2R1 · vitamin D activation
dbSNPTier 3
rs10741657 11:14,914,878 AG

The AG genotype carries one CYP2R1 variant at this locus. CYP2R1 performs the first hydroxylation step in vitamin D activation.

Genotype Table

Variants evaluated in this document — synthetic
rsIDchr:posGenotypeGeneSignificance
rs22826794:72,608,383ACGCTier 1
rs222857012:48,272,895AGVDRTier 3
rs1074165711:14,914,878AGCYP2R1Tier 3
Consult your prescribing clinician. This HelixlyAI report is a synthetic demonstration generated from a consumer DNA export. It is not a diagnosis, prescription, or substitute for professional medical advice. Do not start, stop, or change any medication based on this document. Genotype is one of many factors influencing drug response.